# A Bioequivalence Study Between Two Casdatifan Tablet Strengths and Food Effect Study of Casdatifan in Healthy Adult Participants

> **NCT07641881** · PHASE1 · COMPLETED · sponsor: **Arcus Biosciences, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Casdatifan

## Key facts

- **NCT ID:** NCT07641881
- **Lead sponsor:** Arcus Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-05-29
- **Primary completion:** 2026-07-03
- **Final completion:** 2026-08-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07641881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07641881, "A Bioequivalence Study Between Two Casdatifan Tablet Strengths and Food Effect Study of Casdatifan in Healthy Adult Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07641881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*